Increasing HIV prevention access for Black women
Official title: Trauma-Informed HIV Prevention for Black Women in Baltimore
Run by Johns Hopkins Bloomberg School of Public Health · NCT06703060 · Data updated 2026-11-12
This study is testing a new way to help Black women in Baltimore start taking HIV prevention medication by providing support and resources to overcome challenges they face.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | Johns Hopkins Bloomberg School of Public Health Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | February 28, 2025 |
| Main results expected | December 2027 |
| Study ends | February 2028 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT06703060 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are self-identified Black cisgender women who are HIV-negative, at least 18 years old, and have reported unprotected sex with male partners along with substantial HIV risk factors.
✕Probably not a fit
Patients who are non-English speaking or currently living with HIV will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to implement a multi-level intervention designed to enhance the initiation of pre-exposure prophylaxis (PrEP) among Black women in Baltimore, who are at high risk for HIV. The intervention addresses socio-structural barriers such as intimate partner violence and gendered racism that hinder access to PrEP. By utilizing peer navigation groups, the study seeks to provide support and resources to facilitate PrEP initiation among participants. The effectiveness, implementation, and sustainability of this approach will be assessed throughout the study.
Why it matters
Potential benefit: If successful, this study could significantly increase PrEP initiation rates among Black women, thereby reducing their risk of HIV infection.
How similar studies have gone: While there is limited research specifically targeting this demographic with a multi-level intervention, similar studies have shown promise in addressing barriers to PrEP access in other populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * self-identified Black cisgender woman; * self-reported HIV-negative status, and * ≥18 years. * reports unprotected vaginal or anal sex in the past 6 months with a male sexual partner, * have at least one substantial HIV risk factor in the past 6 months according to the 2021 Centers for Disease Control (CDC) PrEP Eligibility Guidelines (i.e., HIV-positive sexual partner, recent bacterial Sexually Transmitted Disease (STD), 2+ sex partners, history of inconsistent or no condom use, commercial sex work, and residing in high HIV prevalence area or network), and * never taken PrEP Exclusion Criteria: * non-English speaking and * currently living with HIV
Where it's running
-
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Tiara C. Willie, PhD, MA — Johns Hopkins Bloomberg School of Public Health
- Study coordinator: Tiara C. Willie, PhD, MA
- Email: twillie2@jhu.edu
- Phone: 410-614-2686
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PrEP Optimization Through Enhanced Continuum Tracking (PrOTECT AL)
This project will test a real-time PrEP care dashboard and implementation strategies at seven Alabama clinics to see if they increase PrEP coverage and equity among people at risk for HIV.
-
Using PrEP, Doing It for Ourselves (UPDOs)
This project will test whether UPDOs, an online video and telehealth program paired with salon outreach, helps Black cisgender women in the southeastern US learn about and start using PrEP.
-
Pharmacist-guided PEP/PrEP Access Using PEPPI Software
This trial tests whether the PEPPI software helps pharmacists provide PEP/PrEP and helps patients access these HIV prevention options.
-
Feasibility of Online HIV Prevention Research for People Who Inject Drugs
This study tests whether online recruitment and at-home HIV testing can be done reliably by and for people who inject drugs.
-
Familia Imara — a parenting program to reduce family violence in Tanzania.
This program will test whether group parenting sessions led by community health workers can reduce partner violence, lower harsh discipline, and improve child development for couples with a child under two in Tanzanian villages.
-
Culturally tailored, trauma-informed yoga for Black and Brown women who experienced intimate partner abuse
This program will test whether a culturally tailored, trauma-informed yoga program helps Black and Brown women who have experienced intimate partner violence improve psychological well-being compared with enhanced usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.